This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Chitra Kannabiran, PhD, Kallam Anji Reddy Molecular Genetics Laboratory, Hyderabad Eye Research Foundation, Champalimaud Translational Centre, LV Prasad Eye Institute, Hyderabad 500 034, India ...
Retinitis pigmentosa, a degenerative genetic disease of the eye, is characterized by progressive vision loss, usually leading to blindness. In some patients, structural defects in the photoreceptor ...
Retinitis is an eye condition where the tissue at the back of the eyeball becomes inflamed. It can lead to reduced vision and vision loss. The tissue at the back of the eye is known as the retina. It ...
According to Aldeyra Therapeutics, a phase 2/3 trial of ADX-2191 in patients with retinitis pigmentosa is expected to begin in 2025. The Food and Drug Administration (FDA) has granted Fast Track ...
BLOOM (TAMPA) – In a recent episode of the global health and wellness show Bloom, Gayle Guyardo interviewed Dr. Oleg Alekseev, MD, PhD, a renowned Retina Specialist at Duke Eye Center. Dr. Alekseev ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The investigational cell therapy is designed to replace ...
Science and Technology Honors Program, University of Alabama at Birmingham, Birmingham, AL, USA School of Health Professions Honors Program, University of Alabama at Birmingham, Birmingham, AL, USA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results